- Home
- Companies
- switzerland
- bioinformatics
Refine by
Bioinformatics Suppliers Serving Switzerland
106 companies found
based inBangalore, INDIA
Strand Life Sciences is a genomics-based research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Strand Life Sciences partnership programs enable large-scale ...
Since we started in 2000, we have built bioinformatics software for most analytics platforms: microarrays, mass spectrometry, next generation sequencing, high throughput microscopy, and digital PCR. We have covered the spectrum ...
based inState College, PENNSYLVANIA (USA)
SoftGenetics, LLC specializes in the development of genetic analysis tools for both research and diagnostic ...
NextGENe software runs on a Windows® Operating System, which provides a biologist-friendly ‘point & click’ interface. It does not require scripting or other bioinformatics support, which are often required when ...
based inSeongnam-si, SOUTH KOREA
LISCure Biosciences Provides Novel Therapeutics to Patients with Refractory Diseases Using the LMT Platform. LISCure is developing the world’s first injectable immuno-oncology program using non-pathogenic microorganisms. We focus on the development ...
based inSan Diego, CALIFORNIA (USA)
Biomiga, Inc., headquartered in San Diego, California, stands out as an innovative entity in the biotech research and service sector. The company is committed to delivering high-quality laboratory products with exceptional service and support. ...
Quality is key to everything that is done at Biomiga. We rigorously quality check all of our equipment to ensure compliance and have several quality control steps within our processes to deliver the best product. We firmly believe in quality-in ...
based in, NEW JERSEY (USA)
Founded in 2013 by a group of passionate synthetic biologists with decades of industry experience and a proven track record of delivering cost-effective DNA solutions, Synbio Technologies is incorporated with a single mission in mind: to empower ...
Immune Repertoire refers to the set of all functionally diversified B cells and T cells in the circulatory system of an individual at any given time. Immune repertoire sequencing (Immuno-Seq) targets at T/B lymphocytes and utilizes the 5’ ...
based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
Next-generation sequencing (NGS) has the potential to revolutionize the diagnosis and treatment of cancers and rare diseases but creates extremely large, complex, and noisy datasets for analysis. Without the right analytical technology, ...
based inEpalinges, SWITZERLAND
At Alithea Genomics we are committed to developing solutions that simplify and streamline the generation of 'big RNA data', which we believe will constitute the foundation of tomorrow's research and medicine. Our technologies enable our clients to ...
based inBurnaby, BRITISH COLUMBIA (CANADA)
Fusion Genomics is a Vancouver-based company that is advancing molecular diagnostics by developing identification tests for pathogens using proprietary technologies in combination with Next Generation Sequencing. Our ONETest products, in combination ...
FUSIONCloud is the final component in FUSION GENOMICS’ ONETest platform. It is a secure and compliant bioinformatics platform for sensitive and multiplexed pathogen identification from (NGS) data generated by the ONETest ...
based inBrisbane City, AUSTRALIA
Microba’s precise microbiome analysis is built on the expertise of our innovative team at the leading edge of microbiome science. Our approach to microbiome analysis is enabling new discoveries and advancing the understanding of the microbiome in ...
Developing novel therapeutics from the human microbiome; The uncultured portion of the human gut microbiome, which is the majority of microbial species, represents untapped therapeutic opportunity. Microba has established a platform for drug ...
based inAustin, TEXAS (USA)
Asuragen a Bio-Techne brand is a molecular diagnostic product company changing the way patients are treated in genetics and oncology. Asuragen’s diagnostic systems, composed of proprietary chemistry and software, deliver powerful answers using ...
based inAmsterdam, NETHERLANDS
Founded in 1997, Kiadis Pharma is a fully integrated biopharmaceutical company committed to developing innovative, personalized, next-generation cell-based immunotherapies for patients with life threatening diseases. With headquarters in Amsterdam, ...
We believe our IntelliSelect® Technology platforms reduce the risk of missing novel solutions and increase the quality and differentiation of antibodies, to identify product candidates with the most desirable drug-like ...
based inHercules, CALIFORNIA (USA)
Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products ...
Antibodies are one of the most important everyday reagents for biomedical science. In recent years, a number of studies have questioned the reliability of published data and highlighted how low-quality antibodies have contributed to a lack of ...
based inGuildford, UNITED KINGDOM
Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that ...
based inSeoul, SOUTH KOREA
We detect and analyze genomic profile of tumor DNA with a single draw of blood. With this comprehensive profile, we provide personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Ultimately, we ...
The AlphaLiquid® platform enables enhanced safety, speed and efficiency in clinical trials for drug ...
based inHayward, CALIFORNIA (USA)
Biolog, Inc. is a privately held company that began operations in Northern California in 1984. The company’s product lines have been built upon patented technology that greatly simplifies testing of cells. Biolog’s first products were introduced in ...
based inSeoul, SOUTH KOREA
NGS industries are rapidly evolving and our customers are in greater need of technical support in various research fields and markets. Just like a chameleon utilizing its colored pigments and crystals to adapt to its surroundings, we proactively ...
“Unlike Whole Genome Sequencing, Targeted Sequencing is a technique that selectively analyzes specific regional sequences of genomes.” Our Target Enrichment Panel uses hybridization-based capture technology to enable the core process of ...
based inOslo, NORWAY
Bio-Me is Setting the Standard for Routine Microbiome Analysis. Gut microbiome research has become essential to almost every medical research field. Next-generation sequencing (NGS) technologies have been crucial in enabling a breakthrough in our ...
A high-throughput microbiome analysis platform that holds features required for routine clinical applications. Bio-Me’s Precision Microbiome Profiling (PMP™) technology is enabling rapid access to precise gut microbiome data, empowering ...
based inSouth Plainfield, NEW JERSEY (USA)
Admera Health was founded as a spinout from the genetics company Genewiz in 2014 as a clinical genomics company. Now primarily a research service provider, Admera Health combines expert scientific support, advanced laboratory processes, stringent ...
While profiling the transcriptome, many have reported subpopulations of cells that expressed genes at various levels despite originating from a single tissue. The rising popularity of single-cell sequencing has given insight into the extent of ...
based inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
based inJesi (AN), ITALY
Diatech Pharmacogenetics is the Italian leader in the development, production and commercialisation of pharmacogenetics tests for cancer precision medicine. Founded in 1996, Diatech Pharmacogenetics has sustained constant organic growth over the ...